NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA issued several draft local coverage determinations in the last week, including positive coverage decisions for Myriad Genetics' EndoPredict test in breast cancer, CareDx's transplant test AlloSure, and an extension of coverage for Genomic Health's Oncotype DX prostate cancer test to include intermediate-risk patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.